Ever wondered why heart cancer is virtually nonexistent? A riveting new study in Science journal delivers the answer: the heart’s rhythmic pounding mechanically crushes cancer’s ambitions—at least in mice.
Human hearts defy cancer statistics. Primary cardiac tumors? Under 1% in autopsies. Metastatic ones from other sites? Around 18%. The mystery has long intrigued experts, but now Italian researchers led by Serena Zacchigna at the University of Trento provide compelling clues.
Their ingenious setup involved grafting extra, non-contractile hearts onto mouse necks. These ‘spare’ organs got blood flow but no beat. Researchers injected cancer cells into both beating native hearts and these inert transplants.
Drama unfolded fast. Static hearts saw cancer cells rampage, dominating tissue in 14 days. Beating hearts? Cancer barely budged, affecting only a fifth of the area. To confirm, they grew artificial heart tissues in vitro. Calcium triggered beats, mimicking nature. Non-beating versions let lung cancer thrive; pulsing ones kept it in check, forming mere surface nodules.
“This offers a robust explanation,” says James Chong of the University of Sydney. The shear forces and pressures from heartbeats disrupt cancer cell division and migration.
This isn’t ready for prime time—human trials are distant. Yet, it sparks imagination for ‘mechanotherapy’: using vibrations or pressures to starve tumors body-wide. Hearts, it seems, have been fighting cancer all along with every thump.
